Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease [dataset]

Description

In this study, we present amyloid-β-specific engineered CD4+ CAR-T as an approach to directly target sites of pathology. The data is presented in a single spreadsheet file containing all raw data for main and supplementary figures.

Steps to reproduce

Refer to the "Materials and Methods" section of the open-access publication.

Institutions

• Washington University in St. Louis

  Missouri, St Louis
• Weizmann Institute of Science

  Central District, Rehovot
• Hong Kong University of Science and Technology

  Hong Kong
• Dana-Farber Cancer Institute

  Massachusetts, Boston

Categories

Funders

• National Institute on Aging

  National Institutes of Health

  Baltimore

  Grant ID: R01AG078667
• National Institute on Aging

  National Institutes of Health

  Baltimore

  Grant ID: R61AG090394
• Cure Alzheimer’s Fund

  Wellesley

Additional Metadata for Digital Commons Data@Becker

Related Links

Licence